Certificate Number,Certificate
DE_HB_01_GMP_2021_0005,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.1.17  Other: medicinal tea, instant herbal tea(en) 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.6  Quality control testing 1.6.2  Microbiological: non-sterility"
IT/216/H/2022,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
IT/22/H/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Powders(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
NCF/2005/001/CAT,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.4  Impregnated matrices 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.4  Impregnated matrices 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
NCF/2259/001/CAT,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.4  Impregnated matrices 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.4  Impregnated matrices 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
13/12/19ARA,
NBF/1/2020/V,
2020/HPF/FR/011,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2020/HPF/FR/012,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2020/HPF/FR/020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: powder, granules, lozenge(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.3  Chewing gums 1.5.1.8  Other solid dosage forms: powder, granules, lozenge(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
2020/HPF/FR/021,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms: powder, granules, lozenge(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.3  Chewing gums 1.5.1.8  Other solid dosage forms: powder, granules, lozenge(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
22/318530,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: granules, powders(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: granules, powders(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
DK H 00128620,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.6  Other: Powder for injection, infusion and inhalation. Manufacture of sterile API(en) 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: API manufactured by fermentation(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: API manufactured by fermentation(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
DK IMP 00128620,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other 1.1.3  Batch certification 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DK V 00127420,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: For compassionate use(en)
DK V 00127520,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
IT-API/85/H/2020,
OGYÉI/61102-7/2019,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products Special Requirements               : 7  Other: Fresh frozen plasma by plasmapheresis(en)(en)
DE_NW_02_GMP_2020_0003,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.1  Blood products
ES/001HV/20,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing"
ES/001HV/20/1,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing"
ES/004/20,
ES/004/20/1,
ES/005HVI/20,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: [HV] fabricación de principios activos biológicos/ manufacture of biological active substances(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
ES/005HVI/20/1,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products 1.3.1.8  Other: [HV] Fabricación de intermedios y principios activos biológicos/ manufacture of intermediates and biological active substances(en) 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
IWSF.405.5.2020.KK.1 WTC/0161_02_01/7,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Storage and distribution(en) 1.6  Quality control testing 1.6.3  Chemical/Physical
IWSF.405.9.2020.KK.1 WTC/0139_01_01/17,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.13  Tablets 1.2.1.17  Other: raw materials used for preparing medicinal products in the pharmacy according to doctor's prescription or Pharmacopoeia formula(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: raw materials used for preparing medicinal products in the pharmacy according to doctor's prescript(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
IWSF.405.9.2020.KK.2 WTC/0139_02_01/18,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: storage(en)
368/2019/CGMP,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.4  Impregnated matrices 1.2.1.5  Liquids for external use 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.4  Impregnated matrices 1.5.1.5  Liquids for external use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
BE/GMP/2019/103,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification
BE/GMP/2019/104,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification
DE_NW_01_GMP_2019_0016,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Active substance of animal origin.(en)
DK H 00132720,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
ES/009HV/20,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: [HV] Almacenamiento de medicamentos/ Storage of medical products(en)
IWSF.405.3.2020.KK.1 WTC/0162_06_01/5,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
IWSF.405.4.2020.KK.1 WTC/0580_01_01/6,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
LT08H/2019,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
UP/I-530-10/19-03/24; 381-10-05/162-20-14,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.3.2.7  Tissue engineered products 1.3.2.8  Other 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.2.3.7  Tissue engineered products 2.2.3.8  Other 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing 2.3.4  Other: Please see restrictions or clarifying remarks (for all users)(en)
UP/I-530-10/19-03/24; 381-10-05/162-20-15,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.3.2.7  Tissue engineered products 1.3.2.8  Other 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.2.3.7  Tissue engineered products 2.2.3.8  Other 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Please see restrictions or clarifying remarks (for all users)(en)
BE/GMP/2019/113,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.2  Terminally sterilised 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
BE/GMP/2019/114,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
DE_NI_01_GMP_2019_0031,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
ES/006HV/20,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
NL/H/19/2014432,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.1  Blood products 1.3.2.2  Immunological products 1.3.2.3  Cell therapy products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products
2020/HPF/FR/033,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
2020/HPF/FR/040,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Holding(en)
2020/HPF/FR/054,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
2020/HPF/FR/055,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
2020/HPF/FR/124,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
2023_HPF_FR_030,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
IT-API/37/H/2020,
IT/107/H/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Powders; Granules(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Powders; Granules(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
NL/H 19/2007225,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification
NL/H 19/2013760 V1,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 3  Live Cells 5  Radiopharmaceuticals 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 2  Other highly sensitising materials 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products Special Requirements               : 3  Live Cells 1.3.2  Batch Certification (list of product types) 1.3.2.3  Cell therapy products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 1  B-lactam Antibiotics 2  Other highly sensitising materials 1.5.1.13  Tablets Special Requirements               : 1  B-lactam Antibiotics 2  Other highly sensitising materials 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.3  Cell therapy products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
DE_NW_04_GMP_2022_0046,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
480199-13394330,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Globuli(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.4.1.2  Homoeopathic products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Globuli / Tabletten(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: Pflanzliche Rohstoffe / Herbal raw materials(en)
sukls246575/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
NCF/2032/001/CAT,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
051/2019/RO,2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.4  Other: release for sale of imported medicinal products(en)
2021/HPF/FR/028,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powder(en) Special Requirements               : 7  Other: cephalosporins(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets Special Requirements               : 7  Other: cephalosporins(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: powder(en) Special Requirements               : 7  Other: cephalosporins(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets Special Requirements               : 7  Other: cephalosporins(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
2021/HPF/FR/028_ND,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powder(en) Special Requirements               : 7  Other: cephalosporins(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets Special Requirements               : 7  Other: cephalosporins(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: powder(en) Special Requirements               : 7  Other: cephalosporins(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets Special Requirements               : 7  Other: cephalosporins(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
2021/HPF/FR/029,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powder(en) Special Requirements               : 7  Other: cephalosporins(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets Special Requirements               : 7  Other: cephalosporins(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: powder(en) Special Requirements               : 7  Other: cephalosporins(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets Special Requirements               : 7  Other: cephalosporins(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
2021/HPF/FR/029_ND,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powder(en) Special Requirements               : 7  Other: cephalosporins(en) 1.2.1.11  Semi-solids 1.2.1.13  Tablets Special Requirements               : 7  Other: cephalosporins(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: powder(en) Special Requirements               : 7  Other: céphalosporines(en) 1.5.1.11  Semi-solids 1.5.1.13  Tablets Special Requirements               : 7  Other: céphalosporines(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
480910-0007,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical
NBF/39/2020/V,
NBF/55/2019/V,
NBF/56/2021/V,
sukls196422/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
sukls196440/2019,
sukls84146/2020,
2019/HPF/FR/324,2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
2020/HPF/FR/059,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
2020/HPF/FR/063,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
DE_BW_01_GMP_2020_0041,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification
DK API-H 00126920,
DK H 00126920,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.6  Other: Powder for injection, infusion and inhalation. Manufacture of sterile API(en) 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: API manufactured by fermentation(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: API manufactured by fermentation(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration"
ES/145HV/19,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.3  Chemical/Physical
ES/149HV/19,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK GMP 31890 Insp GMP/IMP 31890/16997281-0004 [H],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
UK GMP 31890 Insp GMP/IMP 31890/16997281-0004 [V],1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
481135-101274162,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.1.6  Other: Patientenbezogene Zubereitungen von Zytostatika,  Schmerzpumpen / Patient individual compounding of cytostatics, Analgesics pumps, Patientenbezogene Zubereitungen von Zytostatika,  Schmerzpumpen / Patient individual compounding of cytostatics, Analgesics pumps(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.17  Other: Darmspülpulver zur Colonoskopievorbereitung, Darmspülpulver zur Colonoskopievorbereitung(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Patientenbezogene Zubereitungen von monoklonalen Antikörperlösungen / Patient individual compounding of monoclonal  antibodies, Patientenbezogene Zubereitungen von monoklonalen Antikörperlösungen / Patient individual compounding of monoclonal  antibodies(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Patientenbezogene Zubereitungen von monoklonalen Antikörperlösungen / Patient individual compounding of monoclonal  antibodies, Patientenbezogene Zubereitungen von monoklonalen Antikörperlösungen / Patient individual compounding of monoclonal  antibodies(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.17  Other non-sterile medicinal products: Darmspülpulver zur Colonoskopievorbereitung, Darmspülpulver zur Colonoskopievorbereitung(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
481135-13028004,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.1.6  Other: Patientenbezogene Zubereitungen von Zytostatika,  Schmerzpumpen / Patient individual compounding of cytostatics, Analgesics pumps, Patientenbezogene Zubereitungen von Zytostatika,  Schmerzpumpen / Patient individual compounding of cytostatics, Analgesics pumps(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.17  Other: Darmspülpulver zur Colonoskopievorbereitung, Darmspülpulver zur Colonoskopievorbereitung(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Patientenbezogene Zubereitungen von monoklonalen Antikörperlösungen / Patient individual compounding of monoclonal  antibodies, Patientenbezogene Zubereitungen von monoklonalen Antikörperlösungen / Patient individual compounding of monoclonal  antibodies(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Patientenbezogene Zubereitungen von monoklonalen Antikörperlösungen / Patient individual compounding of monoclonal  antibodies, Patientenbezogene Zubereitungen von monoklonalen Antikörperlösungen / Patient individual compounding of monoclonal  antibodies(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.17  Other non-sterile medicinal products: Darmspülpulver zur Colonoskopievorbereitung, Darmspülpulver zur Colonoskopievorbereitung(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological"
DE_BY_04_GMP_2020_0027,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DE_BY_04_GMP_2020_0028,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_BY_04_GMP_2020_0029,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DK H 00126420,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.10  Radionuclide generators Special Requirements               : 5  Radiopharmaceuticals 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.10  Radionuclide generators Special Requirements               : 5  Radiopharmaceuticals 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DK IMP 00126420,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products Special Requirements               : 5  Radiopharmaceuticals 1.3.1.5  Biotechnology products Special Requirements               : 5  Radiopharmaceuticals 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products Special Requirements               : 5  Radiopharmaceuticals 1.3.2.5  Biotechnology products Special Requirements               : 5  Radiopharmaceuticals 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical 1.6.4  Biological
BE/GMP/2019/075,
BE/GMP/2019/085,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
BE/GMP/2019/127,
CG-HU/22V/2019.,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
DK H 00129320,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products
IT-API/45/H/2020,
IT-API/93/H/2021,
IWPS.405.116.2019.KK.1 WTC/0102_02_01/278,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products 1.3.2  Batch Certification (list of product types) 1.3.2.6  Human or animal extracted products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
IWPS.405.116.2019.KK.2 WTC/0102_02_01/279,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical 1.6.4  Biological
19MPP072HFR01,
19MPP072HFR02,
364/2019/CGMP,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
365/2019/CGMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.5  Packaging 1.5.2  Secondary packaging
DK H 00126320,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products
DK H 00132920,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Reciept and storage of medicinal products, which have not been released. Batch certification is performed by Orifarm Generics A/S, Energivej 15, 5260 Odense S(en) 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation"
DK IMP 00126320,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products
DK IMP 00132920,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Reciept and storage of investigational medicinal products, which have not been released. Batch certification is performed by Orifarm Generics A/S, Energivej 15, 5260 Odense S(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation"
DK V 00132920,"1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: Reciept and storage of medicinal products, which have not been released. Batch certification is performed by Orifarm Generics A/S, Energivej 15, 5260 Odense S(en) 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation"
IWPS.405.114.2019.KK.2 WTC/0172_02_01/274,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.3  Other: sampling of raw and packaging materials(en)
IWPS.405.118.2019.KK.1 WTC/0053_01_01/281,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.4  Other: tablets in-bulk(en)"
IWPS.405.120.2019.KK.2 WTC/0024_01_01/284,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.2  Secondary packaging
IWPS.405.121.2019.KK.1 WTC/0101_01_01/285,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powders(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.1.17  Other: raw materials used for preparing medical products in the pharmacy according to doctor's prescription or Pharmacopoeia formula(en) 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.1  Herbal products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: powders(en) 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: raw materials used for preparing medical products in the pharmacy according to doctor's prescription or Pharmacopoeia formula(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
OGYÉI/57088-5/2019,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases
OGYÉI/57138-7/2019,
sukls248055/2019,
sukls248668/2019,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.4  Biological
481121-0007,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical
482851-0003,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.3  Semi-solids 1.1.1.4  Small volume liquids 1.1.1.6  Other: Patientenbezogene Zubereitungen von Zytostatika / Patient individual compounding of cytostatics(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.2  Semi-solids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Pulvermischungen / Powder mixtures(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.8  Other: Patient individual compounding of monoclonal antibodies(en) 1.3.2  Batch Certification (list of product types) 1.3.2.8  Other: Patient individual compounding of monoclonal antibodies(en) 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.4.2.2  Dry heat 1.4.2.3  Moist heat 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: powders(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical"
BE/GMP/2019/076,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.5  Gamma irradiation 1.6  Quality control testing 1.6.3  Chemical/Physical
BE/GMP/2019/077,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.5  Gamma irradiation 1.6  Quality control testing 1.6.3  Chemical/Physical
BE/GMP/2019/078,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.5  Gamma irradiation 1.6  Quality control testing 1.6.3  Chemical/Physical
BPFMV/057a/009/2019,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.16  Veterinary premixes
ES/104HV/20,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
F022/S2/ME/001/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: powders in sachets(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: powders in sachets(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
F022/S2/MH/001/2020,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms: powders in sachets(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms: powders in sachets(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
NBF/29/2021/V,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
NBF/56/2019/V,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
SK/002V/2020,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological
ES/055HV/20,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
ES/146HV/19,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets
NCF/1953/001/CAT,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: Other(en) 1.1.1.4  Small volume liquids Special Requirements               : 7  Other: Other(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.4  Impregnated matrices Special Requirements               : 7  Other: Other(en) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets Special Requirements               : 7  Other: Other(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.4  Impregnated matrices Special Requirements               : 7  Other: Other(en) 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products"
NCF/2114/001/CAT,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: Other(en) 1.1.1.4  Small volume liquids Special Requirements               : 7  Other: Other(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.4  Impregnated matrices Special Requirements               : 7  Other: Other(en) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids Special Requirements               : 7  Other: Other(en) 1.2.1.12  Suppositories 1.2.1.13  Tablets Special Requirements               : 7  Other: Other(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.4  Impregnated matrices Special Requirements               : 7  Other: Other(en) 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.11  Semi-solids Special Requirements               : 7  Other: Other(en) 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products"
R-311/2019/CGMP,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.6  Liquids for internal use 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
134494/11-11-2019,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products
052/2019/RO,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility
19MPP081HFR01,
19MPP082VFR01,
2020/HPF/FR/045,
BG/GMP/2019/166,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
F005/S1/ME/001/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powders and granules(en) 1.2.1.13  Tablets 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: powders and granules(en) 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
F005/S1/MH/001/2020,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: powders and granules(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: powders and granules(en) 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
NCF/01/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
NCF/02/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
NCF/02/2022,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
NCF/03/2019,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products"
2019/HPF/FR/303,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2019/HPF/FR/304,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2020/HPF/FR/022,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products
2020/HPF/FR/023,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products
481352-0010,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
482419-0003,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: neuverblisterte Arzneimittel / individual medication preparation(en)
CG-HU/08V/2021.,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.16  Veterinary premixes 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.1.16  Veterinary premixes 1.5.2  Secondary packaging
CG-HU/23V/2019.,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.8  Other solid dosage forms 1.2.1.13  Tablets 1.2.1.16  Veterinary premixes 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.5.1.16  Veterinary premixes 1.5.2  Secondary packaging
DK API-H 00132120,
DK API-V 00132120,
DK H 00127120,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Granulates(en) 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: High-dose vitamins and minerals(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Granulates(en) 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation"
IT-API/111/H/2020,
IT-API/146/H/2021,
IT-API/209/H/2019,
IT-API/26/H/2021,
IT-API/68/H/2020,
IT/3/H/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products 1.3.2  Batch Certification (list of product types) 1.3.2.6  Human or animal extracted products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
NBF/23/2020/V,
NBF/43/2021/V,
PCL /2020/001,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
19/13316-21,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2019/HPF/FR/315,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets Special Requirements               : 7  Other: sulphonamides(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets Special Requirements               : 7  Other: sulphonamides(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2019/HPF/FR/316,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.13  Tablets Special Requirements               : 7  Other: sulphonamides(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets Special Requirements               : 7  Other: sulphonamides(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2020/HPF/FR/030,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
2020/HPF/FR/031,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids Special Requirements               : 5  Radiopharmaceuticals 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
C.A.PAP 001/2020,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.1  Blood products 2.3  Other importation activities 2.3.1  Site of physical importation
CG-HU/19V/2019.,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.5  Packaging 1.5.2  Secondary packaging
ES/152I/19,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
OGYÉI/56068-6/2019,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Aqua purificata(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.5  Other: Other terminally sterilized products(en) 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Powders and Granules(en) 1.2.1.11  Semi-solids 1.2.1.12  Suppositories 1.2.1.13  Tablets 1.2.2  Batch certification 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Composite excipients for preparations of the Official Compendium for Prescriptions or Pharmacopoeia(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Powders and granules(en) 1.5.1.11  Semi-solids 1.5.1.12  Suppositories 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
480506-0004,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
BE/GMP/2019/115,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Weighing of API(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.4  Gene therapy products 1.3.2.5  Biotechnology products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.3  Other: Labelling of primary packaging(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: Weighing of API(en) 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.4  Gene therapy products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
ES/038HV/20,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
UK MIA(IMP) 47578 Insp IMP 47578/16159210-0006,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: Aseptically filled sterile sachets(en) 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
22/01/20 ARA,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
2019/HPF/FR/317,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.4  Impregnated matrices 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.4  Impregnated matrices 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: granules(en) 1.5.1.11  Semi-solids 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
BE/GMP/2019/073,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
IT-API/124/H/2020,
IT-API/2/H/2020,
IT-API/206/H/2019,
IT/55/H/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.11  Semi-solids Special Requirements               : 7  Other: Hormones or substances with hormonal activity(en) 1.2.1.13  Tablets Special Requirements               : 7  Other: Hormones or substances with hormonal activity(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.6  Human or animal extracted products 1.3.2  Batch Certification (list of product types) 1.3.2.6  Human or animal extracted products 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.11  Semi-solids Special Requirements               : 7  Other: Hormones or substances with hormonal activity(en) 1.5.1.13  Tablets Special Requirements               : 7  Other: Hormones or substances with hormonal activity(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
NBF/10/2022/V,
NBF/18/2020/V,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
NBF/32/2021/V,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
NBF/43/2019/V,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
SK/003V/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: - Powder for injection for solution - Powder for injection or infusion - Powder for suspension for injection - Powder for sterile solution - Powder for drops - Ointments(en) 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: - Powder for suspension(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: - Powder for suspension(en) 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
SK/016V/2020,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.6  Other: - Powder for injection for solution - Powder for injection or infusion - Powder for suspension for injection - Powder for sterile solution - Powder for drops - Ointments(en) 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.17  Other: - Powder for suspension(en) 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.13  Tablets 1.5.1.17  Other non-sterile medicinal products: - Powder for suspension(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.2  Importation of intermediate which undergoes further processing
6.2.1-2020-056398,
IT-API/188/H/2022,
IWSC.405.55.2019.ABU.1-1 WTC/0105_02_01/276,
DK H 00125819,2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.4  Other: For compassionate use(en)
2019/HPF/FR/351,
DE_NW_06_GMP_2019_0010,
2019/HPF/FR/290,
2019/HPF/FR/291,
2019/HPF/FR/306,
2019/HPF/FR/263,
2019/HPF/FR/318,
2019/HPF/FR/229_NA,
2019/HPF/FR/217,
2019/HPF/FR/217_ND,
2019/HPF/FR/208,
2019/HPF/FR/266,
2019/HPF/FR/267,
2019/HPF/FR/252,
2019/HPF/FR/186,
2019/HPF/FR/187,
2019/HPF/FR/171,
2019/HPF/FR/253,
NL/H 19/2010286 a,
2019/HPF/FR/166,
2019/HPF/FR/201,
2019/HPF/FR/202,
2019/HPF/FR/142,
2019/HPF/FR/064,
2019/HPF/FR/076,
BE/GMP/2018/121,
BE/GMP/2018/122,
2019/HPF/FR/079,
2019/HPF/FR/085,
2019/HPF/FR/055_P_2021,
2019/HPF/FR/092,
2019/HPF/FR/093,
HPF/FR/057/2019,
HPF/FR/058/2019,
NL/H 18/2006860,
IT-API/28/H/2019,
IWZJ.405.121.2018.IPIO.1 WTC/0128_01_01/238,
2019/HPF/FR/009,
2019/HPF/FR/010,
2019/HPF/FR/320,
2019/HPF/FR/321,
DE_BW_01_GMP_2018_0090,
2018/HPF/FR/196,
2018/HPF/FR/197,
OGYÉI/36263-4/2020,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell Special Requirements               : 7  Other: β-lactam antibiotics only(en) 1.2.1.8  Other solid dosage forms: Powders and granules(en) 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell Special Requirements               : 7  Other: β-lactam antibiotics only(en) 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms: Powders and granules(en) 1.5.1.13  Tablets Special Requirements               : 7  Other: including tablets with β-lactam antibiotics(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
2018/HPF/FR/145,
2018/HPF/FR/146,
IT-API/7/H/2022,
2018/HPF/FR/177,
2018/HPF/FR/097,
2018/HPF/FR/098,
2018/HPF/FR/176,
2018/HPF/FR/195,
2018/HPF/FR/101,
2018/HPF/FR/164,
2018/HPF/FR/121,
2018/HPF/FR/122,
2019/HPF/FR/098,
2019/HPF/FR/268,
2019/HPF/FR/268_P_2021,
2019/HPF/FR/269,
2019/HPF/FR/269_P_2021,
2018/HPF/FR/010,
2018/HPF/FR/011,
2018/HPF/FR/012,
2018/HPF/FR/013,
2018/HPF/FR/088,
2018/HPF/FR/089,
HPF/FR/315/2017,
HPF/FR/300/2017,
HPF/FR/301/2017,
NL/H 17/1013488,
HPF/FR/283/2017,
HPF/FR/312/2017,
2018/HPF/FR/256,
2018/HPF/FR/257,
HPF/FR/170/2017,
HPF/FR/247/2017,
HPF/FR/200/2017,
HPF/FR/201/2017,
DK H 00087317,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
HPF/FR/249/2017,
HPF/FR/188/2017,
HPF/FR/141/2017,
HPF/FR/142/2017,
DK H 00086017,
HPF/FR/107/2017,
2019/HPF/FR/335,
2019/HPF/FR/336,
HPF/FR/165/2017,
HPF/FR/166/2017,
13550/ 15-2-17,
2018/HPF/FR/066,
2019/HPF/FR/337,
HPF/FR/026/2017,
HPF/FR/244/2016,
2019/HPF/FR/123,
2019/HPF/FR/124,
480910-0005,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.2.2  Batch certification 1.6  Quality control testing 1.6.3  Chemical/Physical
DE_TH_01H_GMP_2016_0031,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
DK H 00079216,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
DK IMP 00079216,1  MANUFACTURING OPERATIONS 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
LT/07H/2016,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
DE_BB_01_GMP_2017_0008,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.2  Capsules, soft shell 1.5.1.8  Other solid dosage forms 1.5.1.13  Tablets 1.6  Quality control testing 1.6.3  Chemical/Physical"
OGYEI/11013-10/2016,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging
481121-0005,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
OGYÉI/17361-7/2016,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.2  Immunological products 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
022/2016/RO,2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.3  Other importation activities 2.3.1  Site of physical importation
2020/HPF/FR/017,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: hormones(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.2  Semi-solids Special Requirements               : 7  Other: hormones(en) 1.1.2.3  Small volume liquids Special Requirements               : 7  Other: hormones(en) 1.1.2.4  Solids and implants Special Requirements               : 7  Other: hormones(en) 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
2020/HPF/FR/018,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: hormones(en) 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.2  Semi-solids Special Requirements               : 7  Other: hormones(en) 1.1.2.3  Small volume liquids Special Requirements               : 7  Other: hormones(en) 1.1.2.4  Solids and implants Special Requirements               : 7  Other: hormones(en) 1.1.3  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.1  Microbiological: sterility 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.1.4  Biological 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing
OGYÉI/18602-6/2016,
OGYÉI/9215-3/2017,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.1  Large volume liquids 1.1.1.2  Lyophilisates Special Requirements               : 7  Other: including citostatics(en) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.5  Liquids for external use 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms: Powders and granules(en) 1.2.1.11  Semi-solids Special Requirements               : 7  Other: including antibiotics(en) 1.2.1.13  Tablets Special Requirements               : 7  Other: including products with hormonal activity(en) 1.2.1.17  Other: Vaginal rings with hormonal activity(en) 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.5  Biotechnology products 1.3.1.6  Human or animal extracted products 1.3.2  Batch Certification (list of product types) 1.3.2.5  Biotechnology products 1.3.2.6  Human or animal extracted products 1.4  Other products or manufacturing activity 1.4.1  Manufacture of 1.4.1.4  Other: Biological active starting materials(en) 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.5  Liquids for external use 1.5.1.6  Liquids for internal use 1.5.1.8  Other solid dosage forms: Powders and granules(en) 1.5.1.11  Semi-solids Special Requirements               : 7  Other: including antibiotics(en) 1.5.1.13  Tablets Special Requirements               : 7  Other: including products with hormonal activity(en) 1.5.1.17  Other non-sterile medicinal products: Vaginal rings with hormonal activity.(en) 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.2  Microbiological: non-sterility 2.1.3  Chemical/Physical 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.5  Biotechnology products 2.2.3.6  Human or animal extracted products 2.3  Other importation activities 2.3.1  Site of physical importation 2.3.2  Importation of intermediate which undergoes further processing"
OGYÉI/9215-5/2017,"1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.1  Capsules, hard shell 1.5.1.13  Tablets 1.5.1.14  Transdermal patches 1.5.2  Secondary packaging"
13/03/20ARA,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.1  Large volume liquids 1.1.2.3  Small volume liquids 1.1.3  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.3  Chemical/Physical
DK H 00077216,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
DK IMP 00077216,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.1  Filtration 1.6  Quality control testing 1.6.1  Microbiological: sterility 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
sukls110334/2016,"1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.2  Capsules, soft shell 1.2.1.13  Tablets 1.2.2  Batch certification 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.2  Capsules, soft shell 1.5.1.13  Tablets 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical"
BE/GMP/2016/109,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.4  Small volume liquids 1.3  Biological medicinal products (list of product types) 1.3.1  Biological medicinal products (list of product types) 1.3.1.3  Cell therapy products 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical 1.6.4  Biological
PCL01/2016/02,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging
2019/HPF/FR/113,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.5  Gamma irradiation
2019/HPF/FR/114,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.5  Gamma irradiation
2020/HPF/FR/015,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.5  Gamma irradiation
2020/HPF/FR/016,1  MANUFACTURING OPERATIONS 1.4  Other products or manufacturing activity 1.4.2  Sterilisation of active substance/ excipients/ finished product 1.4.2.5  Gamma irradiation
IT-API/99/H/2017,
OGYÉI/16987-7/2016,
OGYÉI/16987-8/2016,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.2  Microbiological: non-sterility 1.6.3  Chemical/Physical
IT-API/38/H/2018,
012/2016/API,
273/2016/CGMP,
DK H 00076816,2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
DK IMP 00076816,2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
DK V 00076816,2  IMPORTATION OF MEDICINAL PRODUCTS 2.3  Other importation activities 2.3.1  Site of physical importation
sukls90162/2016,
ES/088HV/16,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.2  Secondary packaging 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.2  Non-sterile products
480221-0004,1  MANUFACTURING OPERATIONS 1.6  Quality control testing 1.6.3  Chemical/Physical
16MPP027HFR01,
16MPP032HFR,
16MPP032HFR02,
16MPP034HVFR01,
IT-API/90/H/2016,
sukls63634/2016,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical
DK H 00077016,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.4  Other: For compassionate use in DK only (in DK only); Export on certain conditions (please see MIA issued by DHMA)(en)
DK IMP 00077016,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products
DK V 00077016,1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.3  Batch certification 1.2  Non-sterile products 1.2.2  Batch certification 1.3  Biological medicinal products (list of product types) 1.3.2  Batch Certification (list of product types) 1.3.2.2  Immunological products 1.3.2.5  Biotechnology products 2  IMPORTATION OF MEDICINAL PRODUCTS 2.2  Batch certification of imported medicinal products 2.2.1  Sterile products 2.2.1.1  Aseptically prepared 2.2.1.2  Terminally sterilised 2.2.2  Non-sterile products 2.2.3  Biological medicinal products 2.2.3.2  Immunological products 2.2.3.5  Biotechnology products 2.3  Other importation activities 2.3.4  Other: For compassionate use in DK only (in DK only); Export on certain conditions (please see MIA issued by DHMA)(en)
482232-0003,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
482232-0004,1  MANUFACTURING OPERATIONS 1.5  Packaging 1.5.1  Primary Packaging 1.5.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical
ES/136/16*,
ES/136/16**,
481117-0003,1  MANUFACTURING OPERATIONS 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.7  Medicinal gases 1.6  Quality control testing 1.6.3  Chemical/Physical 2  IMPORTATION OF MEDICINAL PRODUCTS 2.1  Quality control testing of imported medicinal products 2.1.3  Chemical/Physical
16MPP033HFR01,
16MPP033HFR02,
DE_BE_01_GMP_2016_0025,"1  MANUFACTURING OPERATIONS 1.1  Sterile products 1.1.1  Aseptically prepared (processing operations for the following dosage forms) 1.1.1.2  Lyophilisates 1.1.1.4  Small volume liquids 1.1.2  Terminally Sterilised (processing operations for the following dosage forms) 1.1.2.3  Small volume liquids 1.2  Non-sterile products 1.2.1  Non-sterile products (processing operations for the following dosage forms) 1.2.1.1  Capsules, hard shell 1.2.1.6  Liquids for internal use 1.2.1.8  Other solid dosage forms 1.2.1.11  Semi-solids 1.2.1.13  Tablets 1.5  Packaging 1.5.2  Secondary packaging 1.6  Quality control testing 1.6.3  Chemical/Physical"
sukls42262/2016,
DK H 00075516,
DK IMP 00076016,
480447-0009,
IT-API/29/H/2017,
IT-API/5/H/2017,
482084-0006,
482084-0009,
BE/GMP/2016/019,
2019/HPF/FR/094,
2019/HPF/FR/095,
HPF/FR/238/2016,
HPF/FR/239/2016,
sukls14256/2016,
sukls3004/2016,
sukls3014/2016,
DE_BE_01_GMP_2016_0047,
DE_SH_01_GMP_2017_0011,
076001/16,
481770-0006,
IT-API/102/H/2016,
IT-API/108/H/2016,
IT-API/109/H/2018,
IT-API/66/H/2016,
IT-API/93/H/2016,
NBF/11/2018/V,
sukls42103/2016,
16MPP029HFR01,
16MPP029HFR02,
481714-0005,
481714-0009,
DK H 00090917,
DK IMP 00090917,
DK API-H 00073316,
MARD 01/2016,
MT/014HM/2016,
sukls2302/2016,
268/2016/CGMP,
ES/113HV/17*,
sukls35423/2016,
sukls41782/2016,
IT-API/28/H/2017,
IT-API/70/H/2016,
IT-API/74/H/2019,
sukls46942/2016,
sukls68153/2016,
16MPP020HVFR01,
16MPP020HVFR02,
16MPP026HFR01,
CG-HU/12V/16.,
DK H 00077716,
DK H 00093117,
OGYÉI/9853-6/2016,
482208-0017,
DE_BY_05_GMP_2016_0105,
sukls14266/2016,
sukls16857/2016,
DK H 00075216,
DK H 00092917,
480777-0070,
DK API-H 00076416,
DK API-V 00076416,
IT-API/123/H/2018,
sukls2990/2016,
DE_BE_01_GMP_2018_0007,
480107-0006,
480777-0062,
480777-0078,
DE_BW_01_GMP_2016_0132,
DE_BW_01_GMP_2016_0133,
DK H 00073016,
DK IMP 00073016,
OGYÉI/11548-3/2017,
OGYÉI/15215-4/2016,
SK/010V/2016,
IT-API/32/H/2024,
sukls41706/2016,
020/2016/RO,
16MB019HFR01,
16MB019HFR02,
16MB019HFR03,
482350-0005,
482350-0007,
DK H 00074016,
FDLB/2016/001,
IT-API/16/H/2017,
IT-API/95/H/2016,
NBF/8/2019/V,
UP/I-530-09/15-19/03; 381-13-04/243-16-17,
DE_NI_03_GMP_2018_0019,
DK IMP 00079516,
OGYÉI/8397-4/2016,
sukls37126/2016,
269/2016/CGMP,
480199-0008,
sukls21290/2016,
482527-0001,
DE_BY_05_GMP_2016_0123,
011/2016/RO,
IT-API/102/H/2017,
MUN01/2016/001,
MUN01/2017/001,
sukls41641/2016,
OGYÉI/7228-6/2016,
DK H 00075016,
DK IMP 00075016,
480311-0013,
16MPP025HFR02,
IT-API/85/H/2018,
16MPP018HFR01,
CG-HU/15V/2016.,
DE_NI_02_GMP_2016_0018,
DK H 00074816,
DK IMP 00074816,
480109-0033,
DK H 00070916,
OGYÉI/5361-8/2016,
OGYÉI/5361-9/2016,
480109-0026,
IT-API/50/H/2016,
DK H 00074216,
IT-API/67/H/2021,
16/00636-23,
267/2016/CGMP,
DE_BB_01_MIA_2017_006,
IT-API/162/H/2018,
IT-API/165/H/2019,
IT-API/218/H/2022,
sukls14251/2016,
sukls18346/2016,
482536-0001,
482536-0006,
482536-0007,
IT-API/122/H/2018,
IT-API/160/H/2017,
IT-API/202/H/2019,
sukls18343/2016,
16MPP008HVFR01,
16MPP008HVFR02,
DK API-H 00073416,
IT-API/73/H/2018,
SK/006V/2018,
16MPP007HVFR01,
DK H 00075416,
DK H 00092317,
DK IMP 00075416,
IT-API/211/H/2020,
MED01/2016/002,
MED01/2018/001,
MED02/2016/001,
MT/006HM/2016,
481272-0006,
481324-0016,
481324-0018,
sukls115805/2015,
266/2016/CGMP,
sukls220362/2015,
16MPP013HFR01,
BE/GMP/2016/003,
sukls155479/2015,
sukls7454/2016,
CG-HU/07V/2016.,
DE_BE_01_GMP_2016_0008,
DK API-H 00072516,
IT-API/73/H/2016,
UNLB 2016/1,
UP/-530-01/15-03/11; 381-13-04/224-16-19,
UP/I-530-09/15-19/05; 381-13-04/244-16-19,
CG-HU/10V/2016.,
16MPP012HFR01,
DK H 00072616,
sukls208621/2015,
480114-0040,
480114-0053,
DE_HE_01_GMP_2016_0063,
DE_HE_01_GMP_2016_0072,
DK H 00071416,
DK IMP 00071416,
sukls201730/2015,
DK H 00071316,
DK IMP 00071316,
DK IMP 00070816,
sukls168341/2015,
15MPP076HFR01,
15MPP076HFR03,
IT-API/30/H/2017,
IT-API/65/H/2016,
UP/I-530-01/15-03/10; 381-13-04/243-16-14,
CG-HU/08V/2016.,
DE_BY_04_GMP_2015_0161,
264/2015/CGMP,
480047-0027,
480047-0028,
480047-0029,
480047-0030,
BE/GMP/2015/157,
DE_RP_01_GMP_2016_0046,
sukls176213/2015,
DE_BB_01_GMP_2016_0024,
482083-0007,
BE/GMP/2015/102,
DK H 00071216,
DK IMP 00071216,
027/2016/RO,
15MPP088HFR01,
15MPP088HFR02,
15MPP088HFR03,
482309-0005,
DK API-H 00074716,
DK H 00074716,
"IN-2-14/16/3 (H,V-relab)",
OGYI/45754-6/2015,
DK H 00067415,
DK IMP 00067415,
ES/040HVI/16,
BE/GMP/2015/122,
482440-0002,
DK V 00071916,
sukls124372/2015,
480078-0028,
481327-0035,
481348-0042,
DK H 00074916,
DK IMP 00074916,
DK V 00074916,
IT-API/8/H/2016,
263/2015/CGMP,
409-9/2015-6,
481348-0034,
DE_BY_05_GMP_2017_0020,
IT-API/41/H/2016,
sukls210609/2015,
DK H 00067115,
DK H 00067215,
VMDGMP/T003/2015,
sukls178270/2015,
261/2015/CGMP,
CG-HU/09V/2016.,
DK H 00067015,
480125-0014,
DE_NW_06_GMP_2015_0020,
DK H 00072316,
DK IMP 00072316,
IT-API/58/H/2016,
15MPP085HFR02,
15MPP087HFR01,
480011-0034,
480011-0040,
480011-0042,
480011-0045,
480011-0048,
480011-0049,
480011-0060,
DK H 00068416,
DK V 00068416,
DK H 00067715,
DK IMP 00067715,
265/2016/CGMP,
480117-0011,
15MPP074HFR01NCS,
15UMB113,
DK H 00068916,
DK V 00068916,
15UMB114HFR01,
258/2015/CGMP,
259/2015/CGMP,
482159-0013,
482159-0026,
482204-0006,
DK H 00067315,
DK H 00072016,
DK H 00072116,
DK H 00072716,
DK IMP 00072016,
DK IMP 00072116,
DK IMP 00072716,
OGYI/40877-7/2015,
OGYI/41236-9/2015,
MT/026HM/2016,
MT/036/HM/2017,
DE_BY_04_GMP_2016_0002,
480356-0005,
IT-API/105/H/2016,
IT-API/61/H/2016,
IT-API/63/H/2016,
IT-API/67/H/2016,
IT/API/M/01/2016,
480019-0031,
480019-0049,
480019-0056,
DK API-H 00082616,
sukls175473/2015,
CG-HU/06V/2016.,
sukls184633/2015,
15MPP082HFR01,
sukls178305/2015,
DK H 00069016,
DK V 00069016,
IT-API/172/H/2017,
15MPP081HFR01,
CG-HU/02V/2016.,
DE_NI_04_GMP_2015_0016,
sukls173140/2015,
CG-HU/11V/2016.,
481329-0007,
DE_BY_04_GMP_2015_0140,
ZVA/LV/2016/001A,
481363-0028,
DK H 00066515,
92/2015,
DE_BY_05_GMP_2016_0056,
DK H 00069816,
DK IMP 00069816,
480747-0024,
482434-0004,
BE/GMP/2015/073,
DK H 00069116,
DK IMP 00069116,
IT-API/32/H/2020,
IT-API/53/H/2018,
482294-0008,
sukls168318/2015,
IT-API/16/H/2016,
IT-API/55/H/2016,
IT/API/M/02/2016,
480587-0004,
sukls172119/2015,
481313-0014,
481313-0016,
CG-HU/17V/2015,
OGYI/35358-7/2015,
OGYÉI/38188-3/2017,
15MPP073HFR02,
DE_BY_05_GMP_2016_0051,
DK H 00063915,
DK IMP 00063915,
CG-HU/03V/2016.,
CG-HU/04V/2016.,
IT/UAO/NCR/MED/1/2015,
sukls167487/2015,
IT/128/H/2016,
SK/032V/2015,
482173-0008,
BPFMV/041/008/2015,
DK H 00066415,
DK IMP 00066415,
15MPP072HFR01,
480050-0068,
480050-0093,
DK H 00068015,
DK IMP 00068015,
482464-0002,
DK IMP 00064715,
15MPP071VFR01,
IT-API/116/H/2017,
IT-API/25/H/2016,
IT-API/28/H/2016,
IT-API/53/H/2016,
IT-API/54/H/2016,
DK H 00077816,
DK V 00077816,
482197-0028,
ES/026HV/16,
HAD01/2016 /001,
SK/031V/2015,
BE/GMP/2015/120,
CG-HU/18V/2015.,
sukls118225/2015,
15MPP069HFR01,
15MPP069VFR01,
IT-API/13/H/2016,
IT-API/18/H/2016,
IT-API/34/H/2016,
DE_BY_05_GMP_2016_0094,
482514-0007,
482514-0008,
OGYÉI/38942-4/2016,
482328-0002,
482328-0003,
482328-0006,
15MPP070HFR01A2,
15MPP070HFR01A3,
15MPP070HFR01A4,
15MPP070HFR01B2,
15MPP070HFR01B3,
DK API-H 00062815,
DK H 00064515,
DK H 00065915,
DK IMP 00064515,
DK IMP 00065915,
DK V 00065915,
IT/135/H/2016,
MT/019HM/2015,
MT/031HM/2017,
15MPP062HFR01,
15MPP062HFR02,
481280-0004,
481280-0005,
DE_BY_05_GMP_2016_0095,
sukls110847/2015,
IT-API/86/H/2019,
UP/I-530-10/15-03/03; 381-13-04/244-15-23,
14/09291-11,
DE_BE_01_GMP_2015_0076,
DE_BE_01_GMP_2015_0077,
sukls109464/2015,
sukls109464/215,
481337-0004,
481337-0005,
481337-0008,
DK H 00064615,
253/2015/CGMP,
481195-0005,
DE_NW_02_GMP_2015_0020,
DK API-H 00067915,
DK H 00066615,
DK IMP 00066615,
481719-0016,
481719-0017,
481719-0018,
suklůs120899/2015,
482156-0005,
481118-0003,
BE/GMP/2015/093,
DK H 00063715,
DK IMP 00063715,
SK/028V/2015,
482297-0002,
482297-0003,
DK H 00065015,
DK IMP 00065015,
DK H 00066715,
DK IMP 00066715,
481721-0002,
480687-0009,
DE_BY_04_GMP_2016_0119,
sukls100679/2015,
038/2015/RO,
DK IMP 00070616,
DK IMP 00070716,
OGYI/28937-7/2015,
BPFMV/040/007/2015,
IT-API/76/H/2018,
480213-0003,
CG-HU/05V/2016.,
DE_BY_04_GMP_2017_1014,
252/2015/CGMP,
15MPP060HFR01NCS,
IT-API/12/H/2016,
IT-API/39/H/2016,
sukls102320/2015,
IT-API/144/H/2015,
REM00/2016/001,
OGYI/29830-5/2015,
OGYI/29830-6/2015,
OGYI/41967-4/2015,
OGYÉI/28026-3/2016,
sukls52111/2015,
sukls92271/2015,
sukls12324/2015,
251/2015/CGMP,
039/2015/RO,
480012-0101,
480012-0113,
481921-0078,
481921-0091,
481921-0092,
481921-0097,
481921-0098,
481921-0111,
BE/GMP/2015/074,
IT/285/H/2015,
15MPP058HFR02,
CG-HU/13V/2015.,
DE_BY_05_GMP_2015_0060,
IT/68/H/2022,
CG-HU/16V/2015.,
481285-0018,
OGYÉI/44525-3/2017,
OGYÉI/60981-8/2017,
OGYÉI/9215-6/2017,
481923-0003,
481923-0006,
NBF/49/2015/V,
482319-0003,
DE_SL_01_GMP_2015_0035,
15MPP059HFR01,
15MPP059HFR02,
DK H 00062915,
DK H 00068516,
DK IMP 00062915,
480100-0004,
481089-0002,
DE_BE_01_GMP_2017_0033,
DK H 00064415,
sukls92014/2015,
DK API-H 00063815,
15MPP053HFR01,
15MPP053HFR02,
481218-0018,
481218-0020,
DE_NI_03_GMP_2015_0022,
HPF/FR/105/2016,
HPF/FR/106/2016,
IT-API/117/H/2017,
IT-API/119/H/2015,
OGYI/20754-7/2015,
OGYI/27285-3/2015,
OGYÉI/54772-3/2017,
sukls93601/2015,
250/2015/CGMP,
480439-0024,
sukls93404/2015,
15UMB066HFR01,
480912-0087,
480912-0090,
sukls51727/2015,
sukls91872/2015,
sukls91874/2015,
15MPP051HFR01,
480912-0074,
480912-0085,
BE/GMP/2015/053,
480001-0138,
480001-0146,
BE/GMP/2015/087,
15UMB061HFR01,
15MPP052HFR01,
IT-API/138/H/2015,
IT-API/31/H/2018,
IT/87/H/2016,
sukls109589/2015,
sukls61247/2015,
sukls81297/2015,
IT-API/134/H/2015,
15/06568,
15MPP047HFR01,
15MPP047HFR02,
15MPP047HFR03,
sukls81100/2015,
482009-0003,
DK H 00061715,
DK IMP 00061715,
OGYI/48796-6/2015,
247/2015/CGMP,
480127-0012,
480127-0017,
480127-0023,
DE_BY_04_GMP_2015_0101,
DE_NW_04_GMP_2015_0063,
BE/GMP/2015/044,
HPF/FR/7/2016,
IT-API/106/H/2016,
IT-API/15/H/2017,
245/2015/CGMP,
481355-0009,
DK IMP 00060515,
OGYI/19246-8/2015,
ZVA/LV/2015/011A,
IT-API/143/H/2015,
sukls69637/2015,
15MPP045HFR01,
15UMB045HFR02,
DK H 00062515,
DK IMP 00062515,
DK V 00062515,
sukls60990/2015,
DK H 00061615,
DK V 00061615,
DK H 00059915,
DK H 00060315,
DK H 00090517,
DK V 00060315,
OGYI/16687-9/2015,
VHP 01/2017,
BGN01/2015/001,
BGN01/2018/001,
IT-API/56/H/2016,
IT-API/68/H/2016,
IT-API/94/H/2015,
2019/HPF/FR/238,
HPF/FR/269/2015,
HPF/FR/146/2015,
HPF/FR/295/2017,
DK H 00045814,
IT/4/H/2009,
DE_RP_01_GMP_2024_0012,
BG/GMP/2024/256,
DE_HH_01_GMP_2024_0014,
10-Mar,
15-Jun,
24-Apr,
DE_HE_01_GMP_2023_0018,
10-Nov,
11-Nov,
12-Nov,
9-Nov,
DE_HE_01_GMP_2022_0171,
DE_HE_01_GMP_2022_0174,
DE_HE_01_GMP_2022_0170,
32578,
DE_HE_01_GMP_2022_0179,
DE_HE_01_GMP_2022_0183,
DE_HE_01_GMP_2022_0172,
MT/043HM/2023,
DE_SL_01_GMP_2022_0027,
FT097/MH/002/2023,
139/6,
DE_HE_01_GMP_2022_0185,
32473,
DE_HE_01_GMP_2023_0037,
NL/V 22/2043225,
409-4/2022-5,
OGYÉI/33400-6/2022,
DE_HE_01_GMP_2022_0196,
DE_ST_01_GMP_2022_0060,
DE_HE_01_GMP_2022_0190,
DE_HE_01_GMP_2022_0201,
409-3/2022-8,
